Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma.

doi:10.1007/s10014-024-00484-x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma.

Brain tumor pathology - 1 Apr 2024

Masui Kenta, Onizuka Hiromi, Muragaki Yoshihiro, Kawamata Takakazu, Kurata Atsushi, Komori Takashi

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms
Share to Cyclin-Dependent Kinase Inhibitor p16
Share to Gene Deletion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutation

Source

Open in PubMed

Identifiers

PMID: 38597998
DOI: 10.1007/s10014-024-00484-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma.PMID 38597998Read ↗

CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas.Semantic proximity Read ↗

Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma.Semantic proximity Read ↗

Intratumoral Heterogeneity: More Than Just MutationsSemantic proximity Read ↗

CDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytoma.Semantic proximity Read ↗

Intratumor heterogeneity reflects clinical disease courseSemantic proximity Read ↗

Marked Intratumoral Heterogeneity of c-myc and CyclinD1 But Not of c-erbB2 Amplification in Breast CancerSemantic proximity Read ↗

Intertumoral Heterogeneity within Medulloblastoma SubgroupsSemantic proximity Read ↗

Intratumoral heterogeneity in kidney cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.